Overview

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effects of rifampin on the pharmacokinetics of dapagliflozin
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Bristol-Myers Squibb
Treatments:
Dapagliflozin
Rifampin